Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally ...
Urolift is a minimally invasive procedure to help treat an enlarged prostate, known as benign prostatic hyperplasia (BPH). Medicare will typically cover Urolift procedures when a doctor deems them ...
BOCA RATON, Fla., Nov. 14, 2018 /PRNewswire-PRWeb/ -- Urology Care Specialists today announced that Dr. David Schwartzwald has been designated as a UroLift® Center of Excellence. The designation ...
Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged ...
CEO Liam Kelly highlighted revenues of $700.7 million for Q1 2025, a decrease of 5% year-over-year on a GAAP basis, aligning with prior guidance. The decline was attributed to EMEA order softness, ...
Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices using the dual levers of acquisitions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback